CHARTWELL RX FDA Approval ANDA 088576

ANDA 088576

CHARTWELL RX

FDA Drug Application

Application #088576

Application Sponsors

ANDA 088576CHARTWELL RX

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL18.75MG0PHENTERMINE HYDROCHLORIDEPHENTERMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1984-05-23
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1988-06-27
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1988-06-27
LABELING; LabelingSUPPL6AP1989-05-02
LABELING; LabelingSUPPL7AP1990-02-16
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1992-10-16
LABELING; LabelingSUPPL11AP1997-12-19
LABELING; LabelingSUPPL12AP1998-04-08
LABELING; LabelingSUPPL13AP1998-08-19
LABELING; LabelingSUPPL14AP1998-11-03
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2000-10-06

Submissions Property Types

SUPPL1Null0
SUPPL4Null0
SUPPL5Null0
SUPPL9Null0
SUPPL16Null0

CDER Filings

CHARTWELL RX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88576
            [companyName] => CHARTWELL RX
            [docInserts] => ["",""]
            [products] => [{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"18.75MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PHENTERMINE HYDROCHLORIDE","submission":"PHENTERMINE HYDROCHLORIDE","actionType":"18.75MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.